How do single-molecule platforms compare with mass spectrometry for throughput in clinical applications?

Single-molecule platforms currently process 50–100 samples per day versus 500+ for high-end mass spectrometry proteomics systems. Clinical labs should evaluate throughput needs against sensitivity gains before committing capital [2]. Read More

What contract structures do CROs typically offer for outsourced protein sequencing?

Most CROs offer per-sample pricing between USD 150 and USD 800, depending on resolution and turnaround. Volume-tiered contracts with guaranteed monthly minimums provide 15–20% discounts over ad-hoc submissions [5]. Read More

Which regulatory filings require complete amino acid sequence analysis data?

All IND and BLA submissions to the FDA and MAA filings to the EMA must include full primary-structure characterization. ICH Q6B mandates sequence confirmation as part of biologic drug substance specifications [8]. Read More

How does the Protein Sequencing Market address post-translational modification mapping?

Advanced mass spectrometry proteomics workflows with enrichment steps identify over 400 modification types. Vendors increasingly bundle PTM-analysis modules into standard peptide sequence determination software packages [9]. Read More

What is the typical payback period for a new mass spectrometry proteomics instrument?

Pharma-grade systems costing USD 0.8–1.5 million achieve payback within 3–4 years at 80%+ utilization. CROs operating at higher throughput often recover costs in under two years [6]. Read More

How are Protein Sequencing Market vendors addressing data-security concerns in cloud analytics?

Leading vendors deploy SOC 2-compliant cloud environments with end-to-end encryption. On-premise deployment options remain available for organizations with strict data-residency requirements [14]. Read More

What training investment should a lab budget when adopting next-gen protein identification technology?

Labs typically allocate USD 15,000–30,000 per operator for vendor certification and bioinformatics training. HUPO recommends a minimum 6-month ramp-up period before achieving validated production throughput [13]. Read More

Protein Sequencing Market (2026 - 2035)

ID: MRFR/LS/5364-HCR

200 Pages

Rahul Gotadki

Last Updated: July 12, 2026

Protein Sequencing Market Research Report: Size, Share, Trend Analysis By Technology (Mass Spectrometry, Edman Degradation, Protein Chip Technology, Nucleic Acid Sequencing), By Applications (Biomedical Research, Drug Discovery, Diagnostics, Proteomics), By End Use (Academic Institutions, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations), By Product Type (Instruments, Reagents, Software, Consumables) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Protein Sequencing Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)4.72%

2025 Market SizeUSD 1.79 Billion

2035 Market SizeUSD 2.98 Billion

Key Players

Thermo Fisher Scientific

Bruker Corporation

Agilent Technologies

Waters Corporation

Shimadzu Corporation

Danaher

Trends

Biologics & Biosimilar Pipeline Expansion
Single-Molecule Sequencing Platform Adoption
CRO Outsourcing Growth

Opportunities

Single-Molecule Sequencing for Point-of-Care Diagnostics
Consumable Subscription and Reagent-as-a-Service Models
Multi-Omics Data Monetization

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Biologics & Biosimilar Pipeline Expansion | |
  2. 3.1.2 Single-Molecule Sequencing Platform Adoption | |
  3. 3.1.3 CRO Outsourcing Growth | |
  4. 3.1.4 AI-Driven De Novo Peptide Sequence Determination | |
  5. 3.1.5 Regulatory Harmonization for Biosimilars | |
  6. 3.1.6 Multi-Omics Integration Demand | |
  7. 3.1.7 Consumable-as-a-Service Business Models |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Instrument Capital Costs | |
  2. 3.2.2 Shortage of Trained Proteomics Specialists | |
  3. 3.2.3 Data Standardization & Interoperability Gaps | |
  4. 3.2.4 Sample Preparation Complexity | |
  5. 3.2.5 Reimbursement Uncertainty for Clinical Proteomics |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Single-Molecule Sequencing for Point-of-Care Diagnostics | |
  2. 3.3.2 Consumable Subscription and Reagent-as-a-Service Models | |
  3. 3.3.3 Multi-Omics Data Monetization | |
  4. 3.3.4 Emerging Market Laboratory Buildouts | |
  5. 3.3.5 Regulatory-Driven Quality Control Mandates |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Protein Sequencing Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Products & Services | |
  1. 5.1.1 Instruments | |
  2. 5.1.2 Reagents & Consumables | |
  3. 5.1.3 Software & Services |
2. 5.2 By Application | |
  1. 5.2.1 Biotherapeutics Quality Control & Discovery | |
  2. 5.2.2 Biomarker Discovery | |
  3. 5.2.3 Protein Engineering Studies | |
  4. 5.2.4 Synthetic Biology & Cell-Free Systems |
3. 5.3 By End User | |
  1. 5.3.1 Pharmaceutical Companies | |
  2. 5.3.2 Contract Research Organizations (CROs) | |
  3. 5.3.3 Academic & Government Institutes | |
  4. 5.3.4 Biotechnology Companies
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Thermo Fisher Scientific | |
  2. 7.3.2 Bruker Corporation | |
  3. 7.3.3 Agilent Technologies | |
  4. 7.3.4 Waters Corporation | |
  5. 7.3.5 Shimadzu Corporation | |
  6. 7.3.6 Danaher (Sciex) | |
  7. 7.3.7 Quantum-Si | |
  8. 7.3.8 Bio-Rad Laboratories | |
  9. 7.3.9 Promega Corporation | |
  10. 7.3.10 PerkinElmer (Revvity)
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI-Augmented Protein Sequencing Workflows |
2. 8.2 Platform Economics and Consumable Lock-In |
3. 8.3 Clinical Proteomics and Companion Diagnostics |
4. 8.4 Sustainability and Green Chemistry in Proteomics
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Protein Sequencing Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Protein Sequencing Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Protein Sequencing Market – Driver Impact Analysis |
TABLE 4 Global Protein Sequencing Market – Restraint Impact Analysis |
TABLE 5 Global Protein Sequencing Market Size, by Products & Services, 2021–2035 (USD Billion) |
TABLE 6 Global Protein Sequencing Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Protein Sequencing Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 8 Global Protein Sequencing Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Protein Sequencing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Protein Sequencing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Protein Sequencing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Protein Sequencing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Protein Sequencing Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix – Global Protein Sequencing Market, 2025 |
TABLE 15 Company Profiles – Key Players, Global Protein Sequencing Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 Report Scope & Methodology Summary |
TABLE 18 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Protein Sequencing Market Dynamics — Drivers, Restraints & Opportunities |
FIGURE 2 Industry Value Chain Analysis — Protein Sequencing Market |
FIGURE 3 Porter's Five Forces Analysis — Protein Sequencing Market |
FIGURE 4 Global Protein Sequencing Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Protein Sequencing Market Share, by Products & Services, 2025 |
FIGURE 6 Protein Sequencing Market Share, by Application, 2025 |
FIGURE 7 Protein Sequencing Market Share, by End User, 2025 |
FIGURE 8 Protein Sequencing Market Share, by Region, 2025 |
FIGURE 9 North America Protein Sequencing Market Share, by Country, 2025 |
FIGURE 10 Europe Protein Sequencing Market Share, by Country, 2025 |
FIGURE 11 Asia-Pacific Protein Sequencing Market Share, by Country, 2025 |
FIGURE 12 Competitive Landscape Positioning Map — Protein Sequencing Market, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
Products & Services	Instruments; Reagents & Consumables; Software & Services	Software & Services (41% share, 2025)	Reagents & Consumables (6.9% CAGR)
Application	Biotherapeutics QC & Discovery; Biomarker Discovery; Protein Engineering Studies; Synthetic Biology & Cell-Free Systems	Biotherapeutics QC & Discovery (39% share, 2025)	Synthetic Biology & Cell-Free Systems (13.1% CAGR)
End User	Pharmaceutical Companies; CROs; Academic & Government Institutes; Biotechnology Companies	Pharmaceutical Companies (57% share, 2025)	CROs (9.2% CAGR)
Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America (46% share, 2025)	Asia-Pacific (9.4% CAGR)

Market Segmentation Overview

By Products & Services

Sub-Segment	Key Trend
Instruments	Platform refresh toward single-molecule and high-resolution mass spectrometry systems
Reagents & Consumables	Recurring revenue from proprietary enzyme kits, columns, and solvent packs
Software & Services	Cloud migration and AI-integrated bioinformatics analytics

The products & services dimension reflects the industry's transition from capital-intensive hardware sales toward a model that emphasizes software subscriptions and consumable annuity streams, mirroring trends seen across the broader life-science instrumentation landscape.

By Application

Sub-Segment	Key Trend
Biotherapeutics Quality Control & Discovery	Mandatory sequence confirmation for biologic and biosimilar regulatory filings
Biomarker Discovery	Growing clinical trial demand for proteomic companion diagnostics
Protein Engineering Studies	Directed evolution and computational enzyme design are driving new workflows
Synthetic Biology & Cell-Free Systems	Rapid prototyping through cell-free expression coupled with real-time sequencing validation

Application segmentation highlights the dominant role of biotherapeutics quality control, which creates non-discretionary demand, alongside the rapid emergence of synthetic biology workflows that require fast-turnaround sequence verification.

By End User

Sub-Segment	Key Trend
Pharmaceutical Companies	Expanding in-house biologics R&D and quality-control infrastructure
Contract Research Organizations (CROs)	Outsourcing-driven throughput growth and per-sample pricing models
Academic & Government Institutes	Grant-funded proteomics core facilities upgrading aging equipment
Biotechnology Companies	Early-pipeline sequence analysis for novel modalities

End-user segmentation underscores the Protein Sequencing Market's reliance on pharmaceutical companies as the primary revenue source, with CROs emerging as the growth engine driven by the broader outsourcing wave in drug development.

By Geography

Sub-Segment	Key Trend
North America	NIH funding, dense pharma HQ clusters, startup innovation hubs
Europe	EMA biosimilar mandates, Horizon Europe research grants
Asia-Pacific	Government biotech initiatives in China and India, CRO hub expansion
South America	FAPESP-led proteomics investment in Brazil
Middle East & Africa	Vision 2030 life-science zones, early-stage market development

Geographic segmentation confirms North America's leadership position, driven by institutional R&D spending, while Asia-Pacific's outsized growth trajectory reflects government-led biotech investment and the rise of India and China as major CRO hubs.

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”